AAAAAA
Results:
1-16
|
Results: 16
Authors:
Ligtenberg, G
Hene, RJ
Blankestijn, PJ
Koomans, HA
Citation: G. Ligtenberg et al., Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus, J AM S NEPH, 12(2), 2001, pp. 368-373
Authors:
Klein, IHHT
Ligtenberg, G
Oey, PL
Koomans, HA
Blankestijn, PJ
Citation: Ihht. Klein et al., Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension, J AM S NEPH, 12(11), 2001, pp. 2427-2433
Authors:
Blankestijn, PJ
Citation: Pj. Blankestijn, Treatment and prevention of catheter-related infections in haemodialysis patients, NEPH DIAL T, 16(10), 2001, pp. 1975-1978
Authors:
Bos, C
Smits, JHM
Zijlstra, JJ
van der Mark, WAMA
Blankestijn, PJ
Bakker, CJG
Viergever, MA
Mali, VPTM
Citation: C. Bos et al., MRA of hemodialysis access grafts and fistulae using selective contrast injection and flow interruption, MAGN RES M, 45(4), 2001, pp. 557-561
Authors:
Simts, JHM
van der Linden, J
Hagen, EC
Modderkolk-Cammeraat, EC
Feith, GW
Koomans, HA
van den Dorpel, MA
Blankestijn, PJ
Citation: Jhm. Simts et al., Graft surveillance: Venous pressure, access flow, or the combination?, KIDNEY INT, 59(4), 2001, pp. 1551-1558
Authors:
Blankestijn, PJ
Ligtenberg, G
Klein, IHHT
Koomans, HA
Citation: Pj. Blankestijn et al., Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance, NEPH DIAL T, 15(6), 2000, pp. 755-758
Authors:
Smits, JHM
van der Linden, J
Blankestijn, PJ
Rabelink, TJ
Citation: Jhm. Smits et al., Coagulation and haemodialysis access thrombosis, NEPH DIAL T, 15(11), 2000, pp. 1755-1760
Authors:
van Schelven, LJ
Oey, PL
Klein, IHI
Barnas, MGW
Blankestijn, PJ
Wieneke, GH
Citation: Lj. Van Schelven et al., Observer variations in short period spectral analysis of heart rate variability, J AUTON NER, 79(2-3), 2000, pp. 144-148
Authors:
Ververs, TFT
van Dijk, A
Vinks, SATMM
Blankestijn, PJ
Savelkoul, TJF
Meulenbelt, J
Boereboom, FTJ
Citation: Tft. Ververs et al., Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration, CRIT CARE M, 28(10), 2000, pp. 3412-3416
Authors:
Smits, JHM
Blankestijn, PJ
Citation: Jhm. Smits et Pj. Blankestijn, Haemodialysis access: the case for prospective monitoring, CURR OP NEP, 8(6), 1999, pp. 685-690
Authors:
Blankestijn, PJ
Smits, JHM
Citation: Pj. Blankestijn et Jhm. Smits, How to identify the haemodialysis access at risk of thrombosis? Are flow measurements the answer?, NEPH DIAL T, 14(5), 1999, pp. 1068-1071
Authors:
van Kempen, BPM
Smits, HFM
Blankestijn, PJ
Citation: Bpm. Van Kempen et al., Haemodialysis access graft with shunting through an iatrogenic fistula - the diagnostic role of magnetic resonance flow measurement, NEPH DIAL T, 14(2), 1999, pp. 444-446
Authors:
Smits, JHM
Blankestijn, PJ
Citation: Jhm. Smits et Pj. Blankestijn, Thrombosis-free hemodialysis grafts: A possibility for the next century?, SEMIN DIAL, 12(1), 1999, pp. 44-49
Authors:
Boereboom, FTJ
Ververs, FFT
Blankestijn, PJ
Savelkoul, TJF
van Dijk, A
Citation: Ftj. Boereboom et al., Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients, INTEN CAR M, 25(10), 1999, pp. 1100-1104
Authors:
Ligtenberg, G
Blankestijn, PJ
Oey, PL
Klein, IHH
Dijkhorst-Oei, LT
Boomsma, F
Wieneke, GH
van Huffelen, AC
Koomans, HA
Citation: G. Ligtenberg et al., Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure, N ENG J MED, 340(17), 1999, pp. 1321-1328
Authors:
El Sharouni, SY
Smits, HFM
Wust, AFJ
Battermann, JJ
Blankestijn, PJ
Citation: Sy. El Sharouni et al., Endovascular brachytherapy in arteriovenous grafts for haemodialysis does not prevent development of stenosis, RADIOTH ONC, 49(2), 1998, pp. 199-200
Risultati:
1-16
|